Paper Details
- Home
- Paper Details
Ceftriaxone-resistant Salmonella enterica serotype typhimurium sequence type 313 from Kenyan patients is associated with the blaCTX-M-15 gene on a novel IncHI2 plasmid.
Author: DouganGordon, KariukiSamuel, KiiruJohn, KingsleyRobert A, LangridgeGemma, NjorogeSamuel, OkoroChinyere, OmuseGeoffrey, RevathiGunturu
Original Abstract of the Article :
Multidrug-resistant bacteria pose a major challenge to the clinical management of infections in resource-poor settings. Although nontyphoidal Salmonella (NTS) bacteria cause predominantly enteric self-limiting illness in developed countries, NTS is responsible for a huge burden of life-threatening b...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432211/
データ提供:米国国立医学図書館(NLM)
Ceftriaxone-Resistant Salmonella: A Threat in Kenya
We're exploring the alarming rise of antibiotic resistance, a global health challenge, and its impact on a specific strain of bacteria, *Salmonella enterica* serotype Typhimurium, in Kenya. This research focuses on a particularly concerning strain, ST313, known for causing severe infections, particularly in sub-Saharan Africa. The study meticulously characterized nine isolates of this strain, all of which were resistant to ceftriaxone, a crucial antibiotic often used to treat bacterial infections. This resistance poses a significant challenge to clinical management, as it limits treatment options.
The researchers used a combination of genetic analysis and microbiological techniques to understand the mechanisms behind the resistance. They discovered that the resistance to ceftriaxone was linked to the presence of the blaCTX-M-15 gene. This gene, found on a novel plasmid called pKST313, allows the bacteria to effectively disarm ceftriaxone.
Ceftriaxone-Resistant Salmonella: A Call for Action
The emergence of this ceftriaxone-resistant strain could have a profound impact on the effectiveness of treating severe infections in sub-Saharan Africa, highlighting the need for vigilant surveillance and the development of new treatment strategies to combat antibiotic resistance.
Ceftriaxone-Resistant Salmonella: A Global Challenge
This study serves as a stark reminder that antibiotic resistance is a global health threat, requiring urgent action to prevent the emergence of untreatable infections. It's a race against time to protect our health and prevent the collapse of our modern medical system.
Dr.Camel's Conclusion
This research emphasizes the urgent need to address antibiotic resistance, a silent threat lurking in our world. It's time to invest in research and development of new antibiotics and implement strategies to prevent the spread of resistant bacteria. The future of healthcare, my friend, depends on it.
Date :
- Date Completed 2016-02-12
- Date Revised 2023-07-10
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.